CorMedix Inc. (CRMD): Strong Sell On Partner Failure, -91.4% Downside: Pump StopperGuest Post
CorMedix Inc. (CRMD): Strong Sell On Partner Failure, Misleading Data And Paid Stock Promotion. -91.4% Downside by Pump Stopper
Also we are NOT an investment advisor but see some of our earlier articles on CRMD
- CRMD’s 1970s-era chemical acquired for <$1m cash from bankruptcy after 2+ failed sale attempts. Bankruptcy documents show Fresenius passed on . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat.